Table IV.
Relationship between PLR, NLR, dNLR, LMR and CSS in patients with RCC who underwent nephrectomy – univariate and multivariate analysis
| Parameter | Univariate analysis | Multivariate analysis* | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| PLR | 1.005 | 1.004–1.006 | < 0.0001 | 1.002 | 1.0–1.003 | 0.094 |
| NLR | 1.183 | 1.127–1.241 | < 0.0001 | 1.041 | 0.965–1.124 | 0.299 |
| dNLR | 1.628 | 1.417–1.869 | < 0.0001 | 1.322 | 1.083–1.614 | 0.006 |
| LMR | 0.595 | 0.515–0.688 | < 0.0001 | 0.937 | 0.807–1.089 | 0.399 |
*
Adjusted for: age (continuous), higher Fuhrman grade (G3-4 vs. G1-2), higher pT category (pT3-4 vs. pT1-2), lymph node involvement (presence vs. absence), distant metastasis (presence vs. absence) and tumor necrosis (presence vs. absence).
PLR – platelet-lymphocyte ratio, NLR – neutrophil-lymphocyte ratio, dNLR – derived neutrophil-lymphocyte ratio, LMR – lymphocyte-monocyte ratio, CSS – cancer-specific survival, HR – hazard ratio, CI – confidence interval.